Age Distribution for T Cell Reactivity to Vaccinia Virus in a Healthy Population

Clinical Infectious Diseases

Volumn 38, Issue 1, 2004, Pages 86-89

  Hsieh, Szu Min ^a   Pan, Sung Ching ^a   Chen, Shey Ying ^a   Huang, Pei Fang ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINIA VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; HEALTH STATUS; HUMAN; IMMUNOREACTIVITY; NONHUMAN; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SCAR; T LYMPHOCYTE; TIME; VACCINATION; VACCINIA; VACCINIA VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOTERRORISM; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; POPULATION; SMALLPOX VACCINE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VACCINIA VIRUS;

EID: 0347859218     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/380460     Document Type: Article

References (13)

1. Cohen J. Smallpox vaccinations: how much protection remains? Science 2001; 294:985.
2. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002; 346:1300-8.
3. El-ad B, Roth Y, Winder A, et al. The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis 1990; 161: 446-8.
4. + cytotoxic T lymphocytes in humans. J Virol 1993; 67:1538-44.
5. Demkowicz WE, Littaua RA, Wang J, Ennis FA. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J Virol 1996; 70: 2627-31.
6. Frey SE, Newman FK, Cruz J, et al. Dose-related effects of smallpox vaccine. N Engl J Med 2002; 346:1275-80.
7. O'Connell CI, Karzon DT, Barron AL, Flaut ME, Ali VM. Progressive vaccinia with normal antibodies: a case possibly due to deficient cellular immunity. Ann Intern Med 1964; 60:282-9.
8. Redfield RR, Wright DC, James WD, Jones TS, Brown C, Burke DS. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 1987; 316:673-6.
9. Hsieh SM, Pan SC, Hung CC, Tsai HC, Chen MY, Chang SC. Association between cytomegalovirus-specific reactivity of T-cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. J Infect Dis 2001; 184:1386-91.
10. Hsieh SM, Pan SC, Hung CC, et al. Kinetics of antigen-induced phenotypic and functional maturation of human monocyte-derived dendritic cells. J Immunol 2001; 167:6286-91.
11. Lopez-Cabrera M, Santis AG, Fernandez-Ruiz E, et al. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 1993; 178:537-47.
12. + T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis [reply; correspondence]. J Infect Dis 2002; 186:1702-3.
13. Hsieh SM, Hung CC, Pan SC, et al. Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: assessment of CD69 expression on T cells after tuberculin stimulation. J Acquir Immune Defic Syndr 2000; 25:212-20.